Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 411

1.

Activation of The Phosphatidylcholine to Lysophosphatidylcholine Pathway Is Associated with Osteoarthritis Knee Cartilage Volume Loss Over Time.

Zhai G, Pelletier JP, Liu M, Aitken D, Randell E, Rahman P, Jones G, Martel-Pelletier J.

Sci Rep. 2019 Jul 4;9(1):9648. doi: 10.1038/s41598-019-46185-w.

2.

An updated algorithm recommendation for the management of knee osteoarthritis from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).

Bruyère O, Honvo G, Veronese N, Arden NK, Branco J, Curtis EM, Al-Daghri NM, Herrero-Beaumont G, Martel-Pelletier J, Pelletier JP, Rannou F, Rizzoli R, Roth R, Uebelhart D, Cooper C, Reginster JY.

Semin Arthritis Rheum. 2019 Apr 30. pii: S0049-0172(19)30043-5. doi: 10.1016/j.semarthrit.2019.04.008. [Epub ahead of print] Review.

3.

Association between metformin use and disease progression in obese people with knee osteoarthritis: data from the Osteoarthritis Initiative-a prospective cohort study.

Wang Y, Hussain SM, Wluka AE, Lim YZ, Abram F, Pelletier JP, Martel-Pelletier J, Cicuttini FM.

Arthritis Res Ther. 2019 May 24;21(1):127. doi: 10.1186/s13075-019-1915-x.

4.

The ratio adipsin/MCP-1 is strongly associated with structural changes and CRP/MCP-1 with symptoms in obese knee osteoarthritis subjects: data from the Osteoarthritis Initiative.

Martel-Pelletier J, Tardif G, Rousseau Trépanier J, Abram F, Dorais M, Raynauld JP, Pelletier JP.

Osteoarthritis Cartilage. 2019 May 16. pii: S1063-4584(19)30978-1. doi: 10.1016/j.joca.2019.04.016. [Epub ahead of print]

PMID:
31102776
5.

Osteoarthritic pain model influences functional outcomes and spinal neuropeptidomics: A pilot study in female rats.

Gervais JA, Otis C, Lussier B, Guillot M, Martel-Pelletier J, Pelletier JP, Beaudry F, Troncy E.

Can J Vet Res. 2019 Apr;83(2):133-141.

PMID:
31097875
6.

Associations of joint line tenderness and patellofemoral grind with long-term knee joint outcomes: Data from the Osteoarthritis Initiative.

Wang Y, Teichtahl AJ, Wluka AE, Pelletier JP, Abram F, Martel-Pelletier J, Cicuttini FM.

Arthritis Care Res (Hoboken). 2019 Apr 22. doi: 10.1002/acr.23906. [Epub ahead of print]

PMID:
31008553
7.

Inflammation and Hypervascularization in a Large Animal Model of Knee Osteoarthritis: Imaging with Pathohistologic Correlation.

Korchi AM, Cengarle-Samak A, Okuno Y, Martel-Pelletier J, Pelletier JP, Boesen M, Doyon J, Bodson-Clermont P, Lussier B, Héon H, Sapoval M, Bureau NJ, Soulez G.

J Vasc Interv Radiol. 2019 Jul;30(7):1116-1127. doi: 10.1016/j.jvir.2018.09.031. Epub 2019 Mar 29.

PMID:
30935868
8.

Relationship between alignment and cartilage thickness in patients with non-traumatic and post-traumatic knee osteoarthritis.

Robbins SM, Abram F, Boily M, Pelletier JP, Martel-Pelletier J.

Osteoarthritis Cartilage. 2019 Apr;27(4):630-637. doi: 10.1016/j.joca.2019.01.002. Epub 2019 Jan 14.

PMID:
30654119
9.

A Phase II Trial of Lutikizumab, an Anti-Interleukin-1α/β Dual Variable Domain Immunoglobulin, in Knee Osteoarthritis Patients With Synovitis.

Fleischmann RM, Bliddal H, Blanco FJ, Schnitzer TJ, Peterfy C, Chen S, Wang L, Feng S, Conaghan PG, Berenbaum F, Pelletier JP, Martel-Pelletier J, Vaeterlein O, Kaeley GS, Liu W, Kosloski MP, Levy G, Zhang L, Medema JK, Levesque MC.

Arthritis Rheumatol. 2019 Jul;71(7):1056-1069. doi: 10.1002/art.40840. Epub 2019 Jun 7.

PMID:
30653843
10.

Machine-learning-based patient-specific prediction models for knee osteoarthritis.

Jamshidi A, Pelletier JP, Martel-Pelletier J.

Nat Rev Rheumatol. 2019 Jan;15(1):49-60. doi: 10.1038/s41584-018-0130-5. Review.

PMID:
30523334
11.

A new decision tree for diagnosis of osteoarthritis in primary care: international consensus of experts.

Martel-Pelletier J, Maheu E, Pelletier JP, Alekseeva L, Mkinsi O, Branco J, Monod P, Planta F, Reginster JY, Rannou F.

Aging Clin Exp Res. 2019 Jan;31(1):19-30. doi: 10.1007/s40520-018-1077-8. Epub 2018 Dec 11.

12.

Knee pain as a predictor of structural progression over 4 years: data from the Osteoarthritis Initiative, a prospective cohort study.

Wang Y, Teichtahl AJ, Abram F, Hussain SM, Pelletier JP, Cicuttini FM, Martel-Pelletier J.

Arthritis Res Ther. 2018 Nov 6;20(1):250. doi: 10.1186/s13075-018-1751-4.

13.

Knee effusion volume assessed by magnetic resonance imaging and progression of knee osteoarthritis: data from the Osteoarthritis Initiative.

Wang Y, Teichtahl AJ, Pelletier JP, Abram F, Wluka AE, Hussain SM, Martel-Pelletier J, Cicuttini FM.

Rheumatology (Oxford). 2019 Feb 1;58(2):246-253. doi: 10.1093/rheumatology/key274.

PMID:
30204907
14.

Impact of oral osteoarthritis therapy usage among other risk factors on knee replacement: a nested case-control study using the Osteoarthritis Initiative cohort.

Dorais M, Martel-Pelletier J, Raynauld JP, Delorme P, Pelletier JP.

Arthritis Res Ther. 2018 Aug 7;20(1):172. doi: 10.1186/s13075-018-1656-2.

15.

High in vivo levels of adipsin lead to increased knee tissue degradation in osteoarthritis: data from humans and animal models.

Valverde-Franco G, Tardif G, Mineau F, Paré F, Lussier B, Fahmi H, Pelletier JP, Martel-Pelletier J.

Rheumatology (Oxford). 2018 Oct 1;57(10):1851-1860. doi: 10.1093/rheumatology/key181.

PMID:
29982662
16.

Clinical diagnosis of partial or complete anterior cruciate ligament tears using patients' history elements and physical examination tests.

Décary S, Fallaha M, Belzile S, Martel-Pelletier J, Pelletier JP, Feldman D, Sylvestre MP, Vendittoli PA, Desmeules F.

PLoS One. 2018 Jun 12;13(6):e0198797. doi: 10.1371/journal.pone.0198797. eCollection 2018.

17.

Initial derivation of diagnostic clusters combining history elements and physical examination tests for symptomatic knee osteoarthritis.

Décary S, Feldman D, Frémont P, Pelletier JP, Martel-Pelletier J, Fallaha M, Pelletier B, Belzile S, Sylvestre MP, Vendittoli PA, Desmeules F.

Musculoskeletal Care. 2018 Sep;16(3):370-379. doi: 10.1002/msc.1245. Epub 2018 May 21.

PMID:
29781110
18.

Exploring determinants predicting response to intra-articular hyaluronic acid treatment in symptomatic knee osteoarthritis: 9-year follow-up data from the Osteoarthritis Initiative.

Pelletier JP, Raynauld JP, Abram F, Dorais M, Delorme P, Martel-Pelletier J.

Arthritis Res Ther. 2018 Mar 1;20(1):40. doi: 10.1186/s13075-018-1538-7.

19.

Diacerein-containing products: same risk of diarrhoea?

Pelletier JP, Martel-Pelletier J.

Aging Clin Exp Res. 2018 Apr;30(4):411-412. doi: 10.1007/s40520-018-0911-3. Epub 2018 Feb 21. No abstract available.

PMID:
29468617
20.

How Do MRI-Detected Subchondral Bone Marrow Lesions (BMLs) on Two Different MRI Sequences Correlate with Clinically Important Outcomes?

Mattap SM, Aitken D, Wills K, Laslett L, Ding C, Pelletier JP, Martel-Pelletier J, Graves SE, Lorimer M, Cicuttini F, Jones G.

Calcif Tissue Int. 2018 Aug;103(2):131-143. doi: 10.1007/s00223-018-0402-8. Epub 2018 Feb 13.

PMID:
29441423
21.

In vivo effect of opticin deficiency in cartilage in a surgically induced mouse model of osteoarthritis.

Farrán A, Valverde-Franco G, Tío L, Lussier B, Fahmi H, Pelletier JP, Bishop PN, Monfort J, Martel-Pelletier J.

Sci Rep. 2018 Jan 11;8(1):457. doi: 10.1038/s41598-017-18047-w.

22.

Corrigendum: ADAM10-mediated ephrin-B2 shedding promotes myofibroblast activation and organ fibrosis.

Lagares D, Ghassemi-Kakroodi P, Tremblay C, Santos A, Probst CK, Franklin A, Santos DM, Grasberger P, Ahluwalia N, Montesi SB, Shea BS, Black KE, Knipe R, Blati M, Baron M, Wu B, Fahmi H, Gandhi R, Pardo A, Selman M, Wu J, Pelletier JP, Martel-Pelletier J, Tager AM, Kapoor M.

Nat Med. 2017 Dec 7;23(12):1499. doi: 10.1038/nm1217-1499b.

PMID:
29216045
23.

Diagnostic validity and triage concordance of a physiotherapist compared to physicians' diagnoses for common knee disorders.

Décary S, Fallaha M, Pelletier B, Frémont P, Martel-Pelletier J, Pelletier JP, Feldman DE, Sylvestre MP, Vendittoli PA, Desmeules F.

BMC Musculoskelet Disord. 2017 Nov 14;18(1):445. doi: 10.1186/s12891-017-1799-3.

24.

Validity of Combining History Elements and Physical Examination Tests to Diagnose Patellofemoral Pain.

Décary S, Frémont P, Pelletier B, Fallaha M, Belzile S, Martel-Pelletier J, Pelletier JP, Feldman D, Sylvestre MP, Vendittoli PA, Desmeules F.

Arch Phys Med Rehabil. 2018 Apr;99(4):607-614.e1. doi: 10.1016/j.apmr.2017.10.014. Epub 2017 Nov 9.

PMID:
29128344
25.

Diagnostic Validity of Combining History Elements and Physical Examination Tests for Traumatic and Degenerative Symptomatic Meniscal Tears.

Décary S, Fallaha M, Frémont P, Martel-Pelletier J, Pelletier JP, Feldman DE, Sylvestre MP, Vendittoli PA, Desmeules F.

PM R. 2018 May;10(5):472-482. doi: 10.1016/j.pmrj.2017.10.009. Epub 2017 Oct 27.

PMID:
29111463
26.

ADAM10-mediated ephrin-B2 shedding promotes myofibroblast activation and organ fibrosis.

Lagares D, Ghassemi-Kakroodi P, Tremblay C, Santos A, Probst CK, Franklin A, Santos DM, Grasberger P, Ahluwalia N, Montesi SB, Shea BS, Black KE, Knipe R, Blati M, Baron M, Wu B, Fahmi H, Gandhi R, Pardo A, Selman M, Wu J, Pelletier JP, Martel-Pelletier J, Tager AM, Kapoor M.

Nat Med. 2017 Dec;23(12):1405-1415. doi: 10.1038/nm.4419. Epub 2017 Oct 23. Erratum in: Nat Med. 2017 Dec 7;23 (12 ):1499.

27.

Intra-articular hyaluronic acid in the treatment of knee osteoarthritis: a Canadian evidence-based perspective.

Bhandari M, Bannuru RR, Babins EM, Martel-Pelletier J, Khan M, Raynauld JP, Frankovich R, Mcleod D, Devji T, Phillips M, Schemitsch EH, Pelletier JP.

Ther Adv Musculoskelet Dis. 2017 Sep;9(9):231-246. doi: 10.1177/1759720X17729641. Epub 2017 Sep 12. Review. Erratum in: Ther Adv Musculoskelet Dis. 2017 Nov;9(11):295.

28.

Refinement of the Montreal Instrument for Cat Arthritis Testing, for Use by Veterinarians: detection of naturally occurring osteoarthritis in laboratory cats.

Klinck MP, Monteiro BP, Lussier B, Guillot M, Moreau M, Otis C, Steagall PV, Frank D, Martel-Pelletier J, Pelletier JP, Del Castillo JR, Troncy E.

J Feline Med Surg. 2018 Aug;20(8):728-740. doi: 10.1177/1098612X17730172. Epub 2017 Sep 18.

PMID:
28920533
29.

Alteration of Wnt5a expression and of the non-canonical Wnt/PCP and Wnt/PKC-Ca2+ pathways in human osteoarthritis osteoblasts.

Martineau X, Abed É, Martel-Pelletier J, Pelletier JP, Lajeunesse D.

PLoS One. 2017 Aug 4;12(8):e0180711. doi: 10.1371/journal.pone.0180711. eCollection 2017.

30.

Levels of serum biomarkers from a two-year multicentre trial are associated with treatment response on knee osteoarthritis cartilage loss as assessed by magnetic resonance imaging: an exploratory study.

Martel-Pelletier J, Raynauld JP, Mineau F, Abram F, Paiement P, Delorme P, Pelletier JP.

Arthritis Res Ther. 2017 Jul 20;19(1):169. doi: 10.1186/s13075-017-1377-y.

31.

Deletion of 12/15-lipoxygenase accelerates the development of aging-associated and instability-induced osteoarthritis.

Habouri L, El Mansouri FE, Ouhaddi Y, Lussier B, Pelletier JP, Martel-Pelletier J, Benderdour M, Fahmi H.

Osteoarthritis Cartilage. 2017 Oct;25(10):1719-1728. doi: 10.1016/j.joca.2017.07.001. Epub 2017 Jul 8.

32.

Reply.

Raynauld JP, Pelletier JP, Martel-Pelletier J, Abram F, Dodin P, Delorme P.

Arthritis Care Res (Hoboken). 2018 Jan;70(1):168. doi: 10.1002/acr.23312. Epub 2017 Dec 7. No abstract available.

33.

Exacerbation of Aging-Associated and Instability-Induced Murine Osteoarthritis With Deletion of D Prostanoid Receptor 1, a Prostaglandin D2 Receptor.

Ouhaddi Y, Nebbaki SS, Habouri L, Afif H, Lussier B, Kapoor M, Narumiya S, Pelletier JP, Martel-Pelletier J, Benderdour M, Fahmi H.

Arthritis Rheumatol. 2017 Sep;69(9):1784-1795. doi: 10.1002/art.40160. Epub 2017 Aug 1.

34.

Spinal neuropeptide modulation, functional assessment and cartilage lesions in a monosodium iodoacetate rat model of osteoarthritis.

Otis C, Guillot M, Moreau M, Martel-Pelletier J, Pelletier JP, Beaudry F, Troncy E.

Neuropeptides. 2017 Oct;65:56-62. doi: 10.1016/j.npep.2017.04.009. Epub 2017 Apr 24.

PMID:
28456437
35.

Analgesic efficacy of tramadol in cats with naturally occurring osteoarthritis.

Monteiro BP, Klinck MP, Moreau M, Guillot M, Steagall PV, Pelletier JP, Martel-Pelletier J, Gauvin D, Del Castillo JR, Troncy E.

PLoS One. 2017 Apr 12;12(4):e0175565. doi: 10.1371/journal.pone.0175565. eCollection 2017.

36.

Erratum to: Diacerein: Benefits, Risks and Place in the Management of Osteoarthritis. An Opinion-Based Report from the ESCEO.

Pavelka K, Bruyère O, Cooper C, Kanis JA, Leeb BF, Maheu E, Martel-Pelletier J, Monfort J, Pelletier JP, Rizzoli R, Reginster JY.

Drugs Aging. 2017 May;34(5):413. doi: 10.1007/s40266-017-0457-7. No abstract available.

PMID:
28349413
37.

Bone curvature changes can predict the impact of treatment on cartilage volume loss in knee osteoarthritis: data from a 2-year clinical trial.

Raynauld JP, Pelletier JP, Delorme P, Dodin P, Abram F, Martel-Pelletier J.

Rheumatology (Oxford). 2017 Jun 1;56(6):989-998. doi: 10.1093/rheumatology/kew504.

PMID:
28339999
38.

Meniscal extrusion and bone marrow lesions are associated with incident and progressive knee osteoarthritis.

Teichtahl AJ, Cicuttini FM, Abram F, Wang Y, Pelletier JP, Dodin P, Martel-Pelletier J.

Osteoarthritis Cartilage. 2017 Jul;25(7):1076-1083. doi: 10.1016/j.joca.2017.02.792. Epub 2017 Feb 13.

39.

Chondroitin sulfate efficacy versus celecoxib on knee osteoarthritis structural changes using magnetic resonance imaging: a 2-year multicentre exploratory study.

Pelletier JP, Raynauld JP, Beaulieu AD, Bessette L, Morin F, de Brum-Fernandes AJ, Delorme P, Dorais M, Paiement P, Abram F, Martel-Pelletier J.

Arthritis Res Ther. 2016 Nov 3;18(1):256.

40.

Osteoarthritis.

Martel-Pelletier J, Barr AJ, Cicuttini FM, Conaghan PG, Cooper C, Goldring MB, Goldring SR, Jones G, Teichtahl AJ, Pelletier JP.

Nat Rev Dis Primers. 2016 Oct 13;2:16072. doi: 10.1038/nrdp.2016.72. Review.

41.

Elucidating the Role of Protandim and 6-Gingerol in Protection Against Osteoarthritis.

Abusarah J, Benabdoune H, Shi Q, Lussier B, Martel-Pelletier J, Malo M, Fernandes JC, de Souza FP, Fahmi H, Benderdour M.

J Cell Biochem. 2017 May;118(5):1003-1013. doi: 10.1002/jcb.25659. Epub 2017 Jan 5.

PMID:
27463229
42.

The unfolded protein response genes in human osteoarthritic chondrocytes: PERK emerges as a potential therapeutic target.

Li YH, Tardif G, Hum D, Kapoor M, Fahmi H, Pelletier JP, Martel-Pelletier J.

Arthritis Res Ther. 2016 Jul 19;18:172. doi: 10.1186/s13075-016-1070-6.

43.

Concurrent validity of different functional and neuroproteomic pain assessment methods in the rat osteoarthritis monosodium iodoacetate (MIA) model.

Otis C, Gervais J, Guillot M, Gervais JA, Gauvin D, Péthel C, Authier S, Dansereau MA, Sarret P, Martel-Pelletier J, Pelletier JP, Beaudry F, Troncy E.

Arthritis Res Ther. 2016 Jun 23;18:150. doi: 10.1186/s13075-016-1047-5.

44.

Analgesic efficacy of an oral transmucosal spray formulation of meloxicam alone or in combination with tramadol in cats with naturally occurring osteoarthritis.

Monteiro BP, Klinck MP, Moreau M, Guillot M, Steagall PV, Edge DK, Pelletier JP, Martel-Pelletier J, Gauvin D, Del Castillo JR, Troncy E.

Vet Anaesth Analg. 2016 Nov;43(6):643-651. doi: 10.1111/vaa.12360. Epub 2016 Feb 24.

PMID:
26913836
45.

Long-Term Effects of Glucosamine and Chondroitin Sulfate on the Progression of Structural Changes in Knee Osteoarthritis: Six-Year Followup Data From the Osteoarthritis Initiative.

Raynauld JP, Pelletier JP, Abram F, Dodin P, Delorme P, Martel-Pelletier J.

Arthritis Care Res (Hoboken). 2016 Oct;68(10):1560-6. doi: 10.1002/acr.22866. Epub 2016 Sep 16.

46.

Diacerein: Benefits, Risks and Place in the Management of Osteoarthritis. An Opinion-Based Report from the ESCEO.

Pavelka K, Bruyère O, Cooper C, Kanis JA, Leeb BF, Maheu E, Martel-Pelletier J, Monfort J, Pelletier JP, Rizzoli R, Reginster JY.

Drugs Aging. 2016 Feb;33(2):75-85. doi: 10.1007/s40266-016-0347-4. Review. Erratum in: Drugs Aging. 2017 May;34(5):413.

47.

Does cartilage volume measurement or radiographic osteoarthritis at baseline independently predict ten-year cartilage volume loss?

McBride A, Khan HI, Aitken D, Chou L, Ding C, Blizzard L, Pelletier JP, Martel-Pelletier J, Cicuttini F, Jones G.

BMC Musculoskelet Disord. 2016 Feb 2;17:54. doi: 10.1186/s12891-016-0900-7.

48.

Efficacy and safety of topical NSAIDs in the management of osteoarthritis: Evidence from real-life setting trials and surveys.

Rannou F, Pelletier JP, Martel-Pelletier J.

Semin Arthritis Rheum. 2016 Feb;45(4 Suppl):S18-21. doi: 10.1016/j.semarthrit.2015.11.007. Epub 2015 Dec 2.

49.

A consensus statement on the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) algorithm for the management of knee osteoarthritis-From evidence-based medicine to the real-life setting.

Bruyère O, Cooper C, Pelletier JP, Maheu E, Rannou F, Branco J, Luisa Brandi M, Kanis JA, Altman RD, Hochberg MC, Martel-Pelletier J, Reginster JY.

Semin Arthritis Rheum. 2016 Feb;45(4 Suppl):S3-11. doi: 10.1016/j.semarthrit.2015.11.010. Epub 2015 Dec 2.

50.

Efficacy and safety of oral NSAIDs and analgesics in the management of osteoarthritis: Evidence from real-life setting trials and surveys.

Pelletier JP, Martel-Pelletier J, Rannou F, Cooper C.

Semin Arthritis Rheum. 2016 Feb;45(4 Suppl):S22-7. doi: 10.1016/j.semarthrit.2015.11.009. Epub 2015 Dec 2.

Supplemental Content

Loading ...
Support Center